<DOC>
	<DOCNO>NCT00583544</DOCNO>
	<brief_summary>Targacept , Inc. study TC-2216 potential role treatment central nervous system ( CNS ) neurobiological disorder anticipation seek indication depression and/or anxiety .</brief_summary>
	<brief_title>A Safety Tolerability Single Ascending Dose Study Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Male subject age 1840 year old ( age include ) . 2 . Subjects must good health determine medical history , physical examination , psychological examination , ECG , vital sign , standard EEG laboratory test . A volunteer clinical abnormality may include Investigator designee considers abnormality introduce additional risk factor subject 's health , interfere study objective . 3 . Subjects body mass index within range 1829 kg/m2 weight within range 6090 kg . 4 . Nonsmoker subject ( cotinine test perform screening Day 1 5 . Subjects must able refrain consume xanthine containing beverage , must refrain intensive physical exercise study conduct ( end study visit ) . 6 . Subjects must sign informed consent form indicate understand purpose procedure require study willing participate study comply study procedure restriction . 7 . Subjects must affiliate , beneficiary , French social security system . Potential subject meet follow criterion exclude participate study : 1 . Any clinically relevant acute chronic disease could interfere subject safety trial , expose undue risk , could interfere study objective . 2 . History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism excretion drug . 3 . Any history drug significant allergy . 4 . Likely need treatment ( include dental care ) study period . 5 . Donation one unit blood within 90 day prior screen . 6 . Use prescription overthecounter medication within 14 day prior admission Day1 ( include paracetamol range 1gr/day ) . In addition medication central effect prohibit period equal 5 x halflife prior admission ( Day1 ) , period longer 14 day . 7 . Alcohol consumption &gt; 40 g alcohol/day ( 1 glass ( 25 cl ) beer 3째 alcohol = 7.5 g , 1 glass ( 25 cl ) beer 6째 alcohol = 15 g , 1 glass ( 12.5 cl ) wine 10째 alcohol = 12 g , 1 glass ( 4cl ) aperitif 42째 alcohol = 17 g ) . 8 . Positive alcotest screening Day 1 . 9 . Positive test result hepatitis B surface antigen , hepatitis C antibody . 10 . Positive test result HIV 1 2 serology . 11 . Excessive daily consumption xanthine contain drink ( i.e &gt; 500 mg/day caffeine ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>